BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE— 510(k) K870807

Substantially Equivalent

Allergan, Inc.

FDA 510(k) clearance K870807 for BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE, Substantially Equivalent on 1987-05-29. Applicant: Allergan, Inc..

Clearance details

Applicant
Allergan, Inc.
Product code
Code HNO
Advisory panel
Ophthalmic
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Santa Ana, CA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code HNO

product code HNO
Injury
390
Total
390

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.